Pfizer-e en es it fr

Pfizer-e Brand names, Pfizer-e Analogs

Pfizer-e Brand Names Mixture

  • No information avaliable

Pfizer-e Chemical_Formula


Pfizer-e RX_link

No information avaliable

Pfizer-e fda sheet

Pfizer-e msds (material safety sheet)

Pfizer-e Synthesis Reference

No information avaliable

Pfizer-e Molecular Weight

167.205 g/mol

Pfizer-e Melting Point

96 oC

Pfizer-e H2O Solubility

2500 mg/L

Pfizer-e State


Pfizer-e LogP


Pfizer-e Dosage Forms

No information avaliable

Pfizer-e Indication

Used for the short-term treatment of insomnia, however, it generally has been replaced by other sedative-hypnotic agents.

Pfizer-e Pharmacology

Ethinamate is used to treat insomnia (trouble in sleeping). However, it has generally been replaced by other medicines for the treatment of insomnia. If ethinamate is used regularly (for example, every day) to help produce sleep, it is usually not effective for more than 7 days. Structurally, it does not resemble the barbiturates, but it shares many effects with this class of drugs; the depressant effects of ethinamate are, however, generally milder than those of most barbiturates. Continued and inappropriate use of ethinamate can lead to tolerance and physical dependence, with withdrawal symptoms very similar to those of the barbiturates.

Pfizer-e Absorption

Rapidly absorbed following oral administration.

Pfizer-e side effects and Toxicity

Symptoms of overdose include shortness of breath or slow or troubled breathing, slow heartbeat, severe weakness, chronic confusion, slurred speech, and staggering.

Pfizer-e Patient Information

Pfizer-e Organisms Affected

Humans and other mammals